BBM BlueberriesMedicalCorp Breaking News CanadianSecuritiesExchange Cannabidiol cannabis Cannabis Buzz CannabisOil CBD ChristianToro Columbia CSE Cultivation Developments Expansion Extraction International Latest Market News Market Research Medical Use MedicalCannabis Operations Producer Products ScientificExpertise strategy TetraHydroCannabinol THC The Market Buzz

Buzz Blue Blue Blue (CSE: BBM)

CDN MSolar and Blueberries Hashish Enterprise Mixture Blueberries for Medical Corp; Shares for commencement of trading on February 6, 2019 The symbol "BBM"

indicates that Blueberries Medical Corp. (CSE: BBM) ("Company" or "Blueberries") is pleased that it has been completed with Blueberries Hashish Corp. "), a leading licensed producer (" transaction ") of cannabis and hashish products. Buying and selling in blueberries (“Blueberries” shares) is predicted to begin on the Canadian Inventory Trade (“CSE”) market, which is open on Wednesday, February 6, 2019 underneath the code “BBM”.

“Public listing in Canada marks another significant milestone for blueberries, as we continue our vision of becoming a world leader in the production of state-of-the-art medicines for cannabis products,” stated Christian Toro, CEO. "By combining Canadian leadership in the cannabis industry, strategic global relationships and Colombian passion and expertise, Blueberries Medical is doing better."

Operational and Enterprise Update

Blueberries are still being promoted to a big scale producer of organically grown cannabis, whose main actions are nicely situated in Bogota's Savannah middle in Colombia. The leader is a specialised staff with expertise in agriculture, genetics, extraction, drugs, pharmacology and advertising. Bilberries have acquired all of the licenses required for the cultivation, manufacturing, domestic distribution and worldwide export of CBD (cannabidiol) and THC (tetrahydrocannabinol). based mostly on medical hashish. The mixture of blueberries with leading scientific experience, agricultural pursuits and distribution preparations has led the company to develop into a number one international provider of naturally grown, processed and standardized medical cannabis oil extracts and associated products

. The corporate has continued to implement its strategic objectives on 6.9.2018. Key occasions embrace:

  • Receiving a cultivation license, making blueberries completely for hashish cultivation, processing / mining and exporting in Colombia and overseas.
  • Accomplished C $ 8,807,500 in personal funding, the place the company was heavily capitalized for progress.
  • Beginning cultivation in a 107,000 ft2 outside greenhouse where business production is predicted This fall 2019.
  • Vital worldwide sales and distribution agreements for products and merchandise being developed
  • Dedicated to a binding letter of intent with Harmonia and Life SAS , which is Colombia's main welfare clinic. The clinic cooperates with blueberries in cannabis-based research, improvement, commercialization and distribution.
  • Continue strengthening the company's management and operational groups (see “New Board of Directors and Management” under)

The company continues its strategic milestones:

  • The enlargement of the company's farm has begun to develop to approximately 861,000 ft2 by the top of 2019 meet the anticipated fast demand. Bilberries are capable of improve their cultivation capacity to about 120 hectares (~ 13 million ft2) of cultivation capability.
  • Know-how and design for hashish oil extraction to deliver oil production in the near future.
  • Extending Product Vary
  • Negotiating Additional Gross sales and Distribution Agreements

Overview of the Event

Overview of the Commerce

The Company, formerly CDN MSolar Corp. merging the company and a wholly-owned subsidiary into three corners. to receive each Blueberries share for every Personal Company share. Instantly before the Transaction was completed, the CDNM modified its identify to “Blueberries Medical Corp.”. The Transaction is a reverse possession proper when the former shareholders of the Personal Firm now personal (undiluted) roughly 93.1% of the issued and remaining blueberries instantly upon completion of the Transaction. On the end of the transaction, 106,622,772 blueberries have been issued Shares, of which 26,441,250 Blueberries Shares have been reserved for circulation in blueberry shares.

For more info on the occasion and the business of blueberries, see
on the itemizing of blueberries, dated 31 January 2019 ("Listing Statement") and revealed on Blueberries issuer profile at SEDAR at

Order Affirmation Financing

Earlier than Closing the Transaction, the Personal Company accomplished a personal placement of $ 8,257,500 ("Offer") on the gross investment revenue of "Subscription Income", which was not a dealer, at a worth of $ zero.25 per order. The proceeds from the supply minus certain costs have been set for the purchase share after the supply ended. Upon completion of the event, the subscription revenue was transformed into a total of 35,230,000 Mustikka shares and 17,615,000 blueberry inventory options, which can be utilized for two years at $ zero.40 per warrant (“Blueberry Options”). Redeemed proceeds from the supply, minus the search charge, and certain transaction charges and costs are exempt from the reserve blueberries. The redemption certificates issued in connection with the supply have been additionally exchanged for comparable blueberry securities.

New Board and Administration

After closing the event, the Board and the Government Group. The corporate was replaced by the following, replacing former CDNM officers and officers and officials

  • Christian Toro, President and CEO
  • Chris Reid, Chief Monetary Officer
  • Camilo Villalba, Chief
  • Andres Castañeda, Country Supervisor
  • Paola Castañeda , Director,
  • Andres Vidal, Director,
  • Francisco Sole, Director,
  • Patricio Villalba, Director,
  • Director,
  • Catherine Lathwell, Director; and
  • Matthew Bajurny, Director.

The biographical descriptions of every blueberry leader and member of the administration group are included within the listing document.

CDN MSolar Corp. discloses conditional approval for its reverse use. C $ eight.eight Million Financing and Ultimate Agreement Signing Blueberries with Cannabis Corp. Enterprise Combination

CDN MSolar Corp. undoubtedly accepted the proposed transaction ("transaction") with Blueberries Cannabis Corp. ("Blueberries"), after which the blueberry shareholders will switch the CDNM. The shares of future issuers (as outlined under) are anticipated to start out trading on CSE underneath the BBM on 6 February 2019 or round 6 September 2019 until the transaction is accomplished.

CDNM and blueberries additionally report that blueberries have ended within the previously introduced personal placement of subscription credit ("Subscription Income"), which raised $ eight.8 million in gross earnings ("Offer"). The supply was completed in several batches and a total of 35,230,000 subscription spaces have been handed over to a worth of $ zero.25 ("Offer Price") per order receipt.

Every order confirmation entitles the holder to the phrases and circumstances of the Task (hereinafter outlined) at the time of the transfer or earlier than it and at no additional value, one unit ("unit") of the capital of the ensuing issuer ensuing from the transaction ("born issuer") referred to as "Blueberries Medical" Corp. " Each unit consists of one share of the resulting issuer ("issued share") and half of the resulting issuer share (each of the full stock option, "born issuer choice"). Each issued issuer option entitles its holder to acquire one share of the issued issuer at a price of $ 0.40 for a period of 24 months after the end of the event. The "Escrowed Funds" earned on the Offer will be repurchased until the following conditions are met: (i) Execution of the Transaction, including without limitation the acceptance and required approvals of all required Shareholders in connection with the Event and conditional approval of the CSE on the list of resulting Issuer Shares; and (b) CDNMs and blueberries that have placed an order with a deposit client for subscription results confirming that the conditions set forth in (i) above have been met or have been waived (collectively, "Escrow Launch Circumstances"). After obtaining conditional approval, CDNM and blueberries will be closed from CSE during the next week when Escrowed Funds will be handed over to the next issuer. If the terms and conditions of the Escrow reservation are not met or are not delivered on 5 February 2019 or before, or if blueberries are notified to the public that it does not intend to meet the Escrow conditions, the subscription income will be canceled and Escrowed Funds returned to the subscribers ("return transaction"). To the extent that there are shortcomings in the return transaction, blueberries provide adequate funds to compensate for such a shortfall

A $ 616,525 cash cost requesting 7% of gross revenue. The Supply, payable to an eligible applicant, and a couple of,466,100 Finder Warrant (s) representing 7% of the gross sales order receipts bought, will probably be awarded to the Qualified Applicant by completing the Escrow Launch Phrases. Each Finder choice entitles the holder to accumulate one unit of $ zero.25 for 24 months after the Transaction is accomplished

CDNM and Blueberries also report having signed a Remaining Business Combination Settlement effective as of February 1, 2019 ("Agreement") with a subsidiary describing the phrases and circumstances underneath which the CDNM and blueberries meet the Transaction. At the end of the occasion, the events intend to proceed to give attention to the production, manufacture and export of medical hashish in Colombia. The Offeror must use the enterprise of the Offeror to increase its enterprise in addition to working capital and basic enterprise purposes. The citation of the shares of the resulting issuers requires that the CDNM complies with all CSE itemizing requirements. There might be no assurance that the proposed transaction can be accomplished in accordance with the present proposal or in any respect.